Alzheimer's Disease Telomerase Gene-Expression Program
exploratoryresearch program · medium
Develop an Alzheimer's disease approach aimed at underlying cell aging mechanisms rather than amyloid removal, tau proteins, or symptomatic treatment.
Targets cell aging, telomere biology, telomerase, and telomerase-related gene-expression resetting; the stated disease model links slowed molecular recycling to beta amyloid accumulation, microaggregates, amyloid plaque, and clinical Alzheimer's disease.
Public website describes the therapeutic rationale and approach; no pipeline stage, trial, candidate name, or development milestone is supplied.